Dopamine and insulin in psychosis
Treatments studied
Part of Mental health clinical trials.
This study looks at how two brain chemicals, dopamine and insulin, work in people with schizophrenia compared to healthy volunteers. It uses MRI scans and other tests to understand these differences, which might lead to better treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 40 years old
- Your body mass index (BMI) is between 18 and 25 (a healthy weight range)
- You are in good general health, with no major medical problems
- You do not have diabetes
- You are not pregnant or breastfeeding
- You are not currently abusing drugs or alcohol (nicotine and caffeine are okay)
- You have no metal implants or other reasons that prevent an MRI scan (a brain imaging test)
- If you are a patient: you have been diagnosed with schizophrenia or schizophreniform disorder
- If you are a patient: you have not taken oral antipsychotics for more than 2 weeks or had a depot (long-acting) antipsychotic injection
- If you are a healthy volunteer: you have no psychiatric illness and no close family member (parent, sibling, or child) with schizophrenia or bipolar disorder
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a nursing program to help people with early psychosis manage weight and reduce the risk of metabolic syndrome (a cluster of conditions that raise heart disease risk). It's designed for people who have had their first psychotic episode within the last 5 years.
This study explores how thinking and memory work in people who have experienced early psychosis. It involves computer tasks, brain scans, and a type of brain stimulation to better understand cognition. The study has two parts: one for people currently in early psychosis and one for people who have had psychosis at any point.
This study tests whether a single dose of a common antipsychotic medication affects how the brain responds to insulin, which could help explain weight gain and metabolic side effects. Healthy young adults will receive either the antipsychotic or a placebo, then have their brain activity measured with an MRI.
This study looks at how a specific type of brain receptor (dopamine-3) works in people with schizophrenia using special brain scans (PET). Researchers want to see how these receptors behave when you are not taking antipsychotic medication, which may help guide future treatments.
This study uses brain scans (MRI) to compare how different antipsychotic medications work in people with psychosis. The goal is to find the best treatment for each person, which could lead to more personalized care.
This study tests whether bromocriptine, a medication that may improve blood sugar control, can help people with schizophrenia who have prediabetes. If you qualify, you might receive the drug or a placebo to see if it helps prevent diabetes.
Hear when a new First Episode Psychosis (FEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.